Learn about rheumatoid vasculitis, neutrophilic dermatoses, and other rheumatoid arthritis rashes, their symptoms, and when ...

Patients with rheumatoid arthritis (RA) face heightened risks for COVID-19 infection, hospitalization, and mortality, according to results of a systematic review and meta-analysis published in BMC ...

A once-daily dose of ivarmacitinib reduced disease activity and improved function among patients with rheumatoid arthritis ...

Anemia is prevalent among patients with rheumatoid arthritis, according to study findings published in Cureus.

A study published in Cureus has highlighted the high prevalence of anemia among patients with rheumatoid arthritis (RA).

Osteoarthritis is caused by the breakdown of cartilage that cushions your joints. Rheumatoid arthritis is an autoimmune disease in which your immune system attacks your body's own tissues in the ...

Biologics for rheumatoid arthritis (RA) are generally quick-acting and effective, but their effectiveness and the time it takes to see results can vary. Many are FDA approved, including adalimumab ...

Other symptoms that may occur during arthritis are fatigue, reduced range of motion, skin rashes, fever, itchy scalp, and unintended weight loss. Experiencing these symptoms can take a heavy toll ...

This means that this advanced goal of remaining in a good health status in regard to rheumatoid arthritis, which should be imminent in the definition of remission, but without the risks associated ...

By Emily Anthes A popular drug for dogs with arthritis may be associated with a variety of potentially severe neurological effects, including seizures and a loss of muscle control, according to a ...

Part of diagnosing rheumatoid arthritis (RA) involves ruling out other conditions that mimic RA, such as fibromyalgia, Lyme disease, and osteoarthritis. Diagnosis involves a physical examination, a ...

What is it? A new skin patch called CopperEase made from copper designed to help relieve joint pain associated with rheumatoid arthritis which affects one in seven people in Britain. How does it work?